Efficacy of intratympanic methylprednisolone injection for the treatment of sudden sensorineural hearing loss (SSNHL): A tertiary centre study
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 7, Pages 2935-2938
AbstractIntroduction: One of the most controversial topics in the otorhinolaryngology literature is the treatment of sudden sensorineural hearing loss. Sudden sensorineural hearing loss (SSNHL) is a rare clinical entity in children. Sudden hearing loss was first documented by de Kleyn in 1944 and defined as hearing loss of at least 30 decibel (dB) in three consecutive frequencies in the standard pure tone audiogram over three days or lessensorineural hearing loss (SSHL). The incidence of SSNHL increases with age, with 8 per 100,000 under the age of 18 years and 70 per 100,000 over 65 years. Early treatment is necessary for preventing permanent hearing loss.
Aims and objectives: To treat sudden sensorineural hearing loss (SSNHL) patients with methylprednisolone injection intratympanically and to evaluate its outcome
Materials and methods:
Total cases: 6 cases of Sudden Sensorineural hearing loss due to occupational hazards out of 35 cases of Sensorineural hearing loss.
Study period: February 2022 to August 2022
Methods: Pure tone Audiometry and Tympanometry
Occupation of patients: Generator operator, other heavy machinery operator etc.
Study Selection: retrospective on the treatment of patients diagnosed as having SSHL.
Place of study: Diphu Medical College & Hospital, Karbi Anglong, Assam
Cases were followed up every alternate days for 4 settings of intratympanic steroid
All cases are being followed regularly on 6 monthly basis
All cases were advised to wear an ear plug whenever they visit their workplace or any noisy place
Results: All cases will be discuss after competition of the study.
Conclusion: Intratympanic steroid is an excellent way to manage sudden severe sensorineural hearing loss.
- Article View: 22
- PDF Download: 18